TOP OF THE PAGE
|
Arrhytmias in athletes
endurance training, vagally-mediated heart rate recovery, heart rate spectral
analysis, hypertension, dynamic exercise, sympatho-vagal balance, OA, RT-219
heart rate varibility, sympatho-vagal balance modulation, power spectrum analysis,
endurance training, physiologic vagotonia induced by training, pathologic conditions, OA, RT-222
neurally mediated syncope, middle-aged subjects, highly-trained athletes,
medium-trained subjects, sedentary subjects, head-up tilt testing, physical training
degree, OA, RT-217
top-level athletes, atrial fibrillation, prolonged palpitations, transoesophageal
atrial pacing/recoding, electrophysiologic testing, OA, RT-223
sudden death, commotio cordis syndome, blunt chest blow, ventricular disrhythmia,
electrical vulnerable period of repolarization, preventive measures, cardiopulmonary
resuscitation measures, systemic sports training/competition, OA, RT-221
sudden death, congenital/acquired conduction system abnormalities, Alaskan sled dogs,
Iditarod race, strenuous physical activity, R, RT-220
ventricular arrhythmias, subclinical heart disease, frequent/complex arrhythmias,
cardiovascular preparticipation screening, late potentials, myocardial biopsy,
echocardiography, magnetic resonance imaging, OA, RT-218
|
TOP OF THE PAGE
|
Arrhytmogenic right ventricular dysplasia
congestive heart failure, dilated cardiomyopathy, wall motion abnormalities, rest,
exercise, heart transplantation, OA, RT-207
famial disease, family studies, progressive disease, gene disease, autosomic dominant
disease, ventricualar arrhythmias, congestive heart failure, late potentials, exercise
rest, pharmacologic treatment, ICD, young patients, asymptomatic/symptomatic patients, OA, RT-209
surface 12 -lead ECG, signal averaged ECG, late potentials, repolarization
abnormalities in right precordial leads, ventricular arrhythmias, left bundle branch block
QRS configuration, OA, RT-208
ventricular arrhythmias, heart muscle disorder, magnetic resonance imaging,
echocardiography, right ventricular angiography, familial disease, gene disease, young
male, exercise, major/minor diagnosis criteria, functional/morphological characteristics,
OA, RT-205
ventricular arrhythmias, left bundle branch block QRS configuration, magnetic resonance
imaging, echocardiography, suden death, young male, exercise, OA, RT-204
ventricular arrhythmias, magnetic resonance imaging, echocardiography, class I, II,
IV drugs, angiotensin converting enzym inhibitor, propafenone, OA, RT-206
|
TOP OF THE PAGE
|
Arrhytmhogenesis
long QT syndrome, controle of ventricular repolarization, gene disease, genotype,
phenotype, OA, RT-135
silent myocardial ischemia, ischemia threshold, circadian variations, ACIP, autonomic
nervous system, R, RT-134
thrombus fomation, acute ischemia, ST-changes, conductin delay, OA, RT-133
ventricular fibrillation threshold, trigger/substrate interaction, defibrillation
threshold, inhomogeneity of repolarisation, QT dispersion, R, RT-132
|
TOP OF THE PAGE
|
Atrial fibrillation
atrial pacing, effective refractory period, electrical remodelling, prediction of
arrhythmias, OA, RT-49
atrial refractoriness, non-invasive assessment, dominating atrial cycle length,
di-sotalol, sympathetic stimulation, vagal stimulation, OA, RT-76
catheter ablation in right atrium, atrial mapping, atrial activation pattern, OA, RT-81
catheter ablation, multisite mapping of activation, Multipolar Mapping Basket
Catheter, R, RT-79
idiopathic atrial fibrillation, atrial endocardial mapping, patterns of activation,
OA, RT-78
paroxysmal AF, interatrial conduction time, P wave duration, interatrial septum
pacing, OA, S-2
paroxysmal atrial fibrillation, anatomic patterns, bipolar electrogram patterns,
atrial effective refractory period, OA, RT-77
propafenone, prophylaxis of atrial fibrillation, hemodialysis patients, OA, RT-53
quality of life, social demographic data, family
interaction, hobby activities, personality structure, muscle tension, anxiety, Freiburger
personality inventory, ICD therapy, OA, RT-14
radiofrequency catheter ablation, AV node ablation, AV node modulation, AF substrate
ablation, Framingham study, R, S-3
recent onset, conversion of atrial fibrillation to sinus rhythm, drug protocols,
Framingham study, OA, RT-54
recent onset, class 1c drugs, conversion of atrial fibrillation to sinus rhythm, OA, RT-56
recurrent paroxysmal atrial fibrillation, atrial pacing, dual chamber pacemaker, role
of intra-atrial conduction, OA, RT-58
recurrent paroxysmal atrial fibrillation, atrial pacing, dual chamber pacemaker,
bradi-tachycardia patients, sinus sick syndrome, chronotropic incompetence, OA, RT-59
recurrent paroxysmal atrial fibrillation, consisten atrial pacing algorithm, Holter
ECG, OA, R-57
refractory AF, chronic AF, implantable atrial
defibrillator, discomfort, safety, efficacy, tolerability, proarrhythmia, Metrix
multicenter clinical trial, Framingham study, OA, RT-191
tachycardia induced atrial fibrillation, radiofrequency catheter ablation, role of
supraventricular tachycardias, clinical implications, R, RT-80
|
TOP OF THE PAGE
|
Atrial fibrillation - electrophysiology
elctrophysiology substrate, mapping, catheter ablation, electrical remodeling, R, RT-75
left atrial appendage wall velocity, cycle length of AF waves, Doppler
echocardiography, tissue Doppler imaging, pulsed wave tissue Doppler imaging, OA, RT-245
mechanisms of AF perpetuation, computerized analysis of intra-atrial potentials,
refractoriness, conduction velocity, wave-length of circulating impulse, OA, RT-247
non-fluoroscopic electro-anatomical mapping, ablation of arrythmogenic substrates, OA,
S-23
pacing-induced AF, atrial effective refractory period, coronary artery disease,
dilated cardiomyopathy, mechanisms of AF perpetuation, OA, RT-246
|
TOP OF THE PAGE
|
Atrial fibrillation – RF catheter ablation
of AV junction
dual chamber pacemaker, pacing mode (DDD, DDDR, VDD), automatic mode-switch
activations/day ratio, quality of life, OA, RT-145
paroxysmal AF, brady-tachy syndrome, pacemaker (DDD, VVI mode), OA, RT-149
paroxysmal AF, chronic AF, clinical outcome, mortality rate, thromboembolisms, OA, RT-147
paroxysmal AF, pacemaker (DDDR mode), pharmacological treatment, epidemiology, quality
of life, PAF trial, OA, RT-146
refractory ventricular ectopic beats, right ventricular otflow tract, right ventricle
abnormalities, magnetic resonance imaging, echocardiography, OA, RT-152
refractory ventricular ectopic beats, right ventricular outflow tract, OA, RT-151
right ventricular tachyarrhythmias, left bundle brunch block configuration, idiopathic
ventricular tachyarrhythmias, right ventricualr cardiomyopathy, OA, RT-150
supraventrucular arrhythmias, pacemaker (DDD, VVIR mode), ventricular function, NYHA
class, echocardiography, dicumarol, OA, RT-148
|
TOP OF THE PAGE
|
Atrial fibrillation – thromboembolic events
anticoagulation therapy, calcic and sodium heparin, dicoumarol, transoesophageal
echocardiography, ACUTE trial, OA, RT-142
anticoagulation therapy, warfarin, thrombus resolution, thrombus organization,
transoesophageal echocardiography, OA, RT-141
anticoagulation therapy, warfarin, thrombus resolution, thrombus organization,
transoesophageal echocardiography, OA, RT-143
intra-atrial thrombus, apendage thrombus, onset of arrhythmias, transoesophageal
echocardiography, OA, RT-140
|
TOP OF THE PAGE
|
Atrial fibrillation - transthoracic electrical
cardioversion
atrial contractile function, risk of thromboembolism, atrial stunning, heart rate,
role of permanent atrial pacing, OA, RT-139
defibrillator paddle position, DC-schock energy requirements, transthoracic impedance,
antero-posterior versus antero-lateral position, OA, RT-136
efficacy, optimal cardioversion energy, adverse events, risk stratification of stroke,
anticoagulation therapy, OA, RT-137
predictors of cardioversion, arrhythmia duration, history of previous episodes of AF,
OA, RT-138
|
TOP OF THE PAGE
|
Atrial fibrillation – transvenous internal
cardioversion
AF defibrillation threshold, external cardioversion, antiarrhythmic therapy influence,
class I, Ic, III drugs, propafenone, amiodarone, d-sotalol, flecainide, R, RT-189
low energy atrial cardioversion, P wave signal averaging, time domain analysis,
frequency domain ananlysis, prediction of early AF relaps, OA, RT-188
low energy atrial cardioversion, right atrium-coronary sinus configuration, right
atrium-left pulmonary artery configuration, atrial defibrillation threshold, pain
torelability, safety, efficacy, pharmacologic pre-treatment, biphasic shock, indications,
OA, RT-187
low energy atrial defibrillation, chronic AF, ventricular proarrhythmia, inter-subject
variability in schock tolerability, step-up protocol for schock delivery, pain
torelability, OA, RT-185
low energy atrial defibrillation, endocavitary atrial cardioversion, external
cardioversion, indications, atrial defibrillation threshold, right atrium-right ventricle
coil-lead configuration, pain torelability OA, RT-186
low energy atrial defibrillation, ICD, ICD inappropriate incidences, single/dual
pathway simultaneous biphasic shocks, patch electrode, OA, RT-184
|
TOP OF THE PAGE
|
Autonomic nervous system evaluation
GISSI-3 Arrhythmias subtrial, lisinopril, transdermal glyceryl trinitrate,
arrhythmogenic substrate, postmyocardial patients, ventricular function, mortality risk,
Holter ECG, OA, RT-211
heart rate variability, markers of vagal/sympathetic modulation, high-frequency
spectral component, low-frequency spectral component, sympatho-vagal balance, neural code,
R, RT-213
lethal arrhythmias, postmyocardial patients, left ventricular function, heart rate
variability, baroreflex sensitivity, reflex chronotropic response to a blodd pressure
change, autonomic markers, risk stratification, EMIAT trial, MADIT trial, ATRAMI trial, R,
RT-212
neurocardiogenic syncope, baroreceptor function, head-up tilt testing, autonomic
control of circulation, OA, RT-210
|
TOP OF THE PAGE
|
Brugada, Martini-Nava syndromes
sudden death, middle-aged patients, right bundle branch block, right precordial ST
segment elevation, V1-V3 ECG leads, ventricular fibrillation, beta-blockers, amiodarone,
ICD indication, family ECG screening, OA, RT-243
sudden death, ventricular fibrillation, family incomplete bundle branch block, right
precordial ST segment elevation, intraventricular delay, right ventricle dysplasia
cardiomyopathy syndrome, magnetic resonance imaging, genetic screening, ICD indication,
OA, RT-244
sudden death, young patients, right bundle branch block, right precordial ST segment
elevation, ventricular fibrillation, syncope, arrhythmogenic right ventricular
cardiomyopathy, conduction system disease, OA, RT-242
|
TOP OF THE PAGE
|
Cardiac arrhythmias - classification
atrial tachycardia classification, tachycardia substrate geometry, substrate-based
classification, focal atrial tachycardia, syndrome of inappropriate sinus tachycardia,
macro-reentrant atrial tachycardia, atrial fibrillation, R, RT-178
atrial-ventricualr arrhythmias, anatomical nomenclature, anatomic inaccuracy, uniform
heart structures terminology, R, RT-177
|
TOP OF THE PAGE
|
Cardiac arrhythmias - epidemiology
borreliosis, Lyme disease, cardiac arrhythmias, risk assessment, bootstrap method, RT-87
health economics, Sweden, drug costs, pacemakers, cardiac operations, ICD, RT-88
public health system, DRGs, hospital productivity, analysis of resource use, financing
hospitals, Catalog of Medical Acts, USA, Italy, France, OA, RT-89
registry of pacemakers, registry of ICD, Europe, OA, RT-90
statistical analysis, epidemiologic methods, analysis of arrhythmologic literature,
OA, RT-86
|
TOP OF THE PAGE
|
Cardiac arrhythmias – gender differences
diagnostic/therapeutic procedures, acute ischemic syndrome, bradyarrhythmias, Austrian
Pacemaker Database, quality of treatment, epidemiology, Yentl syndrome, sinus sick
syndrome, AV block, selection of pacing mode, gender discrimination of management,
thrombolytic therapy, TAMI trial, OA, RT-240
pacemaker implantation, diagnostic/therapeutic procedures, coronary artery disease,
postmenopausal women, selection of pacing mode, single-lead pacing (VVI, VVI-R mode),
sequential pacing mode (DDD, DD-R, DD-M), European Pacemaker Patient Identification Card,
gender discrimination of management, OA, RT-241
postmyocardial infarction, crude mortality, congestive heart failure, diabetes,
hypertension, ventricular arrhythmias, aspirin, beta-blockers, nitrates, coronary artery
bypass graftings, OA, RT-239
|
TOP OF THE PAGE
|
Cardiac arrhythmias – mapping
atrial tachycardia, mapping techniques, AP interval, atrial activation, pacemapping
concordant sequence, radiofrequency catheter ablation, automaticity of ectopic focus,
intra-atrial/sino-atrial node reentry, OA, RT-195
epicardial mapping, endocardial mapping, postmyocardial patients, pleomorphic
ventricular tachycardia, radiofrequency catheter ablation, OA, RT-192
|
TOP OF THE PAGE
|
Cardiac surgery - arrhythmias
atrial fibrillation, mitral valve disease, left atrial isolation, Maze operation, OA, RT-93
ectopic atrial tachycardia, radiofrequency ablation, corridor procedure, Maze
operation, R, RT-91
|
TOP OF THE PAGE
|
Catheter ablation of supraventricular
tachyarrhythmias
atrial flutter (typical - type I), index of successful ablation,
anatomic/electrophysiologic approach, bidirectional conduction block, right atrial
activation sequence, OA, RT-161
atrial flutter, counterclockwise circular activation, mechanisms of induction of AFl,
programmed stimulation, OA, RT-160
atrial flutter, recurrence of AF, class Ia, Ic, III drugs, propafenone, flecainide,
amiodarone, sotalol, quinidine, OA, RT-162
atrioventricular junctional reciprocating tachycardia, slow pathway ablation, AV node
modification, junctional accelerated rhythm, OA, RT-157
inappropiate sinus tachycardia, chronic non-paroxysmal sinus tachycardia,
beta-blockers, verapamil, surgery, catheter ablation, R, RT-158
|
TOP OF THE PAGE
|
Heart rate variability
acute myocardial infarction, late potentials, left ventricular ejection fraction, risk
stratification, OA, RT-105
essential hypertension, heart rate spectral analysis, aerobic exercise training,
sympatho-vagal activity, dynamic exercise, isometric exercise, hypotensive effect of
exercise training, OA, RT-233
fractal dimension analysis, non-linear dynamics analysis, postischemic recovery,
prediction of arrhythmias, OA, RT-51
myocardial infarction, arrhythmogenic right ventricular cardiomyopathy, ventricular
arrhythmias, Holter ECG, time domain analysis, autonomic nervous system, sympathetic
activity, OA, RT-232
post myocardial infarction, cardiac rehabilitation, time domain, frequency domain,
autonomic nervous system, OA, RT-231
|
TOP OF THE PAGE
|
Hypertrophic cardiomyopathy
implantable cardioverter defibrillator, antiarrhythmic drug therapy, R, RT-30
markers of sudden death (clinical, ECG), risk factor stratification, programmed
electrical stimulation, treatment of risk factors, R, RT-29
sudden death, risk factor stratification, T wave alternans, QT interval dispersion, R,
RT-31
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator –
function, indications
automatic sensitivity programming, sensing circuitry, automatic sensitivity control,
R, S-9
cellular phones, electromagnetic interference, TACS technology, GSM technology,
programming and telemetric check up, OA, RT-99
defibrillation efficacy, defibrillation threshold, biphasic shock, OA, RT-203
dual chamber ICD, DDD pacing, DDDR pacing, VDD pacing, VVI (ventricular) pacing, DDI
pacing, DDIR pacing, severe left ventricular function, atrium/ventricle sensing-pacing,
indications, inappropriate ICD incidences, beta-blockers, postinfarction patients, dilated
cariomyopathy, hypertrophic obstructive cardiomyopathy, R, RT-201
dual chamber ICD, single chamber ICD, ICD inappropriate
incidences, atrial signal analysis, arrhythmia detection algorithm, discrimination
ventricular/supraventricular tachycardias, OA, S-114
dual chamber pacing, dual chamber detection algorithm, discrimination ventricular
arrhythmias versus supraventricular arrhythmias, therapy ventricular arrhythmias versus
supraventricular arrhythmias, prevention, OA, S-4
infectious complications, non-thoracotomy/thoracotomy approach, prevention, treatment,
staphylococcus aureus, R, RT-101
painless defibrillator, electrical shock, loss of consciousness, pain, quality of
life, inappropriate ICD incidences, OA, RT-202
prediction of arrhythmias, RR variability, OA, S-8
prophylactic ICD trials, ventricular arrhythmias, CASH trial, CIDS trial, AVID trial,
R, S-6
supraventricular arrhythmias, atriventricular discrimination algorithm, SMART
algorithm, OA, S-10
ventricular tachycardia, antitachycardia pacing algorithms, CR, S-11
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator – new
perspectives
dual chamber ICD, atrial sensing-pacing, arrhythmias detection algorithms, ICD
inappropriate incidences, R, S-164
dual chamber ICD, clinical results, ICD inappropriate incidences, atrial
sensing-pacing, atriventricular association algorithm, French multicenter trial, VAN
detection algorithms, R, S-166
dual chamber ICD, low energy cardioversion, antitachycardia pacing, defibrillation,
antibradycardia pacing, atrial pacing, atrioventricualr pacing, atrial sensing-pacing,
paroxysmal AF, ventricualr tachycardia/fibrillation, sudden cardiac death, R, S-165
dual chamber ICD, ventricualr signal-based detection criteria, atrial-sensing-pacing,
atriventricular association algorithm, PARAD decision tree, detection of RR intervals,
ventricular tachycardia persistence, R, S-167
single chamber ICD, dual chamber ICD, arrhythmias therapy, arrhythmias detection,
pacemaker function, Holter ECG, R, S-163
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator –
primary prevention of sudden death
postinfarction patients, prophylatic ICD implantation, MADIT trial, clas I, III drugs,
amiodarone, dl-sotalol, beta-blockers, CABG trial, MUSTT trial, SCD-HeFT trial, MADIT II
trial, BEST ICD trial, left ventricular function, non-sustained ventricular tachycardia,
mortality rate, cost-effectivenes analysis, R, RT-216
postinfarction patients, prophylatic ICD implantation, MADIT trial, left ventricular
function, non-sustained ventricular tachycardia, MADIT II trial, CAST trial, SWORD trial,
EMIAT trial, CAMIAT trial, AVID trial, CASH trial, CIDS trial, risk stratification,
electrical instability evaluation technique, mortality rate, R, RT-215
prophylatic ICD implantation, postinfarction patients, CAST trial, class I drugs,
MADIT trial, EMIAT trial, CAMIAT trial, left ventricular function, non-sustained
ventricular tachycardia, risk stratification, mortality rate, R, RT-214
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator -
therapy
ICD inappropriate incidences, detection criteria, supraventricular tachycardia,
morphology discrimination algorithm, OA, S-115
ICD inappropriate incidences, detection criteria, supraventricular tachycardia,
prevention of inappropriate incidences, stability criteria, onset criteria, R, S-113
|
TOP OF THE PAGE
|
Long QT syndrome
congenital/acquired syndrome, lethal tachyarrhythmias, sympathetic cardiac
reflexogenic modulation, neuronal degeneration, thoracic spinal cord sympathetic center,
OA , RT-225
malignant ventricular arrhythmia, body surface mapping, functional, morphological and
clinical features, primary cardioneuropathy, OA, RT-94
|
TOP OF THE PAGE
|
Major clinical trials
EMIAT trial, ECG Holter substudies, CAMIAT trial, CHF STAT trial, amiodarone,
arrhytmia risk markers, postinfarction patients, reduced left ventricular ejection
fraction, beta-blockers, high heart rate, R, RT-180
EMIAT trial, amiodarone, postinfarction patients, reduced left ventricular ejection
fraction, beta-blockers, high heart rate, mortality risk, R, RT-179
ICD, MADIT trial, ventricular tachycardias, sudden death, mortality risk, arrhythmia
risk, reduced left ventricular ejection fraction, FDA, European Guidelines, postinfarction
patients, CABG-Patch trial, AVID trial, SCD-HeFT trial, MADIT II trial, DEBUT trial,
NORDIC trial, BEST-ICD trial, R, RT-183
primary prevention of ventricular arrhythmias, secondary prevention of ventricular
arrhythmias, CAST trial, CAST II trial, BASIS trial, Polish arrhythmia trial, CASCADE
trial, SWORD trial, ESVEM trial, EMIAT trial, CAMIAT trial, GESICA trial, CHF STAT trial,
MADIT trial, AVID trial, class I, Ic, III drugs, moricizine, amiodarone, dl-sotalol,
d-sotalol, ICD, antiadrenergic action, proarrhythmia, R, RT-182
|
TOP OF THE PAGE
|
Mechanisms of arrhythmogenesis - experimental
arrhythmology
heart failure, failing ventricular myocytes, cellular ionic mechanisms, arrhythmogenic
mechanisms, OA, RT-83
sino-atrial node, Purkinje fibers, high K+ , sympathetic system, OA, RT-84
|
TOP OF THE PAGE
|
Molecular biology - mechanisms of
arrhythmogenesis
automacity, triggered activity, reentry, CAST trial, R, S-64
|
TOP OF THE PAGE
|
Molecular biology - structural anatomy and
pathology
apoptosis, arrhythmogenic right ventricular cardiomyopathy, programmed cell death,
cardiac morphogenesis, apoptic bouts, arrhythmogenesis, R, RT-128
atrioventricular conduction system, electrophysiological mapping, histologic
investigation of transcatheter ablation lesions, OA, RT-122
atrioventricular conduction system, variations in morphology, transcatheter ablation
therapy, R, RT-123
congenital cardiac diseases, gene disease, long QT syndrome, hypertrophic
cardiomyopathy, arrhythmogenic right ventricular dyspalsia, famial aftrial fibrillation,
familial WPW syndrome, familal heart block, idiopathic ventricular fibrillation,
Brugada´s syndrome, R, RT-126
congenital cardiac diseases, gene disease, mechanisms of arrhythmogenesis, torsade de
pointes, long QT syndrome, congenital complete heart block, cellular ionic mechanisms,
hypertrophy, postinfarction remodeling, heart failure, R, RT-125
myocardial structure abnotmalities, arrhythmogenesis, recurrent arrhythmias, automatic
arrhythmias, reentrant arrhythmias, R, RT-124
|
TOP OF THE PAGE
|
Norepinephrine, acetylcholine
Purkinje fibers, arrhythmogenic actions, norepinephrine-acetylcholine interaction, OA,
RT-52
|
TOP OF THE PAGE
|
Pacemakers
cellular phones, electromagnetic interference, TACS technology, GSM technology,
proarrhythmic effects, OA, RT-97
|
TOP OF THE PAGE
|
Pacing
electrode configuration, DDD pacemakers, OA, RT-24
electrode configuration, DDD pacemakers, OA, RT-25
morphological and biological changes of myocardium, structure of the heart, OA, RT-28
multiplesite pacing, electrode configuration, congestive heart failure, OA, RT-26
paroxysmal atrial arrhythmias, drug refractoreness, multisite atrial pacing, R, S-1
peak endocardial accelaration, ischemic heart disease, OA, RT-40
VDD pacemakers, DDD pacemakers, radionuclide ventriculography, Fourier analysis, OA, RT-39
VDD pacemakers, follow-up, single pass lead, OA, RT-38
|
TOP OF THE PAGE
|
Pacing – congestive heart failure
arrhythmic events, sudden death, dilated cardiomyopathy, risk stratification,
echocardiography, Holter ECG, signal-averaged ECG, heart rate variability indexes, OA, RT-235
atrial fibrillation, cardiac output, catheter ablation of AV junction, right
ventricular pacing, exercise performance, quality of life, OA, RT-238
dual chamber pacing, optimized-programmed AV interval, dilated cardiomyopathy, Italian
Study on Stimulation in Cardiomyopathy/ISSC trial, left ventricular filling, OA, RT-237
non-sustained ventricualr tachycardia, sudden death, Holter ECG, Italian Network for
Congestive Heart Failure, Captopril-Digoxin trial, GESICA trial, angiotensin converting
enzyme inhibitors, V-Heft II trial, enalapril, GISSI-3, lisinopril, benazapril, CONSENSUS
trial, amiodarone, proarrhythmia, OA, RT-234
|
TOP OF THE PAGE
|
Pacing assessment – follow-up
atrial sensed-ventricular paced stimulation, optimal atrioventricular delay, Doppler
echocardiography, OA, RT-120
cause of chest pain, oesophageal pain threshold, oesophageal electrical stimulation,
echocardiography stress testing, transoesophageal cardiac pacing, OA, RT-119
DDD pacemakers, interatrial conduction time, interatrial electromechanical conduction
time, Doppler echocardiography, Doppler mitral velocity wave, OA, RT-118
interatrial septum dual chamber pacemaker, VDD pacing, DDD pacing, optimal
atrioventricular delay, Doppler echocardiography, OA, RT-121
|
TOP OF THE PAGE
|
Pacing leads
removal methods, transfemoral approach, transjugular approach, OA, RT-100
|
TOP OF THE PAGE
|
Peadiatric arrhythmias - management
neurocardiogenic syncope, tilt-up testing, beta-blockers, OA, RT-196
radiofrequency catheter abaltion, safety, indications, effectiveness, OA, RT-199
sustained atrial tachycardia, electrophysiologic patterns, radiofrequency catheter
ablation, atrial programmed stimulation, OA, RT-200
ventricular repolarization time indexes, tetralogy Fallot post-operation patients,
electrical myocardial instability, ventricular arrhythmias, sudden death, ventricular
recovery time indexes, OA, RT-197
ventricular/supraventricular tachyarrhythmias, amiodarone, propranolol, drug
resistance, atrioventricular reentry tachycardia, OA, RT-198
|
TOP OF THE PAGE
|
QT interval
QT dispersion, acute myocardial infarction, OA, RT-44
QT dispersion, aortic stenosis, ventricular repolarization, ventricular recovery, OA, RT-47
QT dispersion, obese patients, exercise stress test, sudden death, OA, RT-42
QT dispersion, RR intervals, Holter ECG, OA, RT-43
RR intervals, healthy subjects, OA, RT-41
|
TOP OF THE PAGE
|
Radio frequency catheter ablation of
tachyarrhythmias
atrial arrhythmias, mapping - ablation, intracardiac echocardiography, assessement of
anatomic lesions, R, RT-109
atrioventricular nodal fast pathway, parahissian accessory pathways, sinus
tachycardia, transient parasympathetic denervation of sinus node, OA, RT-110
atrioventricular nodal reentrant tachycardia, slow pathway approach, transoesophageal
atrial pacing/recording, OA, RT-227
myocardial lesion, antimyosine monoclonal antibodies, heart-lung index,
echocardiogram, OA, RT-107
orthoptic cardiac transplantation, recipient - donor heart, postoperative arrhythmias,
R, RT-108
|
TOP OF THE PAGE
|
RR interval, repolarization, heterogeneity,
variability
Holter ECG, ventricular repolarization dynamics, QT interval, QR-RR relation, LQT
syndrome, LQT genotype, d-sotalol, quinidine, circadian patterns, ST changes, risk
stratification, autonomic nervous system, R, RT-172
dispersion of ventricular repolarisation, RR variability, RR/RT-apex varibility
interaction, RR-QT coupling, ventricular repolarization duration, OA, RT-173
paroxysmal AF, Holter ECG, Laser Holter System, atrial refractory period, CRAFT trial,
autonomic nervous system, macro-reentrant basis, atrial ectopic activity, non-electrical
trigger factors, OA, RT-174
QT interval dispersion, ectopic ventricular beats, inhomogeneity of ventricular
recovery time, 12-lead ECG, ECG leads configutation, arrhythmogenesis, OA, RT-175
|
TOP OF THE PAGE
|
Signal averaged ECG
acute myocardial infarction, heart rate variability, left ventricular ejection
fraction, risk stratification, OA, RT-105
heart rate variability, late potentials, predictors of clinical outcome, acute
myocardial infarction, left ventricular ejection fraction, OA, RT-104
late potentials, mitral valve prolapse, myxomatous degeneration of mitral valve, risk
of sudden death, OA, RT-106
paroxysmal atrial fibrillation, time domain analysis, frequency domain analysis, high
frequency components, OA, RT-103
|
TOP OF THE PAGE
|
ST-segment alterations
supraventricular tachycardia, ventricular repolarization, OA, RT-46
|
TOP OF THE PAGE
|
Sudden death
Chagas´heart disease, public health problem, insect vector, blood transfusion,
congenital form, dilated cardiomyopathy, ventricular arrhythmias, bradyarrhythmias, heart
failure, embolismus, proarrhythmia, amiodarone, R, RT-168
post myocardial patients, behavioral-psychological factors, depression, premature
ventricular contractions, cardiac mortality risk, CAPS trial, dopamine tone, autonomic
nervous system, R, RT-169
T-wave alternans, mortality risk stratification, prolongation of repolarization,
electrical alternans, left bundle branch block, hypertrophic cardiomyopathy, long QT
syndrome, R, RT-170
young population, congenital anomaly, anomalous coronary artery origin, strenous
exercise, premature coronary atherosclerosis, vasospasm, triggers, right ventricular
cardiomyopathy, athletes, hypertrophic cardiomyopathy, WPW syndrome, aortic rupture, R, RT-171
|
TOP OF THE PAGE
|
Syncope
adenosine triphosphate sensitivity, atrio-ventricular conduction, OA, RT-34
aortic stenosis, vasodepressor response, cardioinhibitory response, R, RT-32
head-up tilt testing, nitroglycerin, OA, RT-35
head-up tilt testing, orciprenaline, OA, RT-33
head-up tilt testing, orthostatic intolerance, tilt training, OA, RT-36
head-up tilt testing, salt intake, OA, RT-37
|
TOP OF THE PAGE
|
Third degree interatrial block
paroxysmal tachyrrhythmias, medical treatment, synchronous biatrial pacing, R, RT-12
|
TOP OF THE PAGE
|
Treatment of arrhythmias – mechanisms
CAST trial, SWORD trial, GESICA trial, EPAMSA trial, BASIS
trial, PAT trial, CHF-STAT trial, EMIAT trial, CAMIAT trial, class Ic, III drugs,
amiodarone, Sicilian Gambit, molecular biology, gene disease, ICD therapy, AVID trial,
MADIT trial, primary prevention, secondary prevention, CABG-Patch trial, R, S-7
molecular arrhythmology, congenital long QT syndrome, gene disease, heart failure,
sudden death, cellular changes in ion channels, electrical remodeling, CAST trial,
Sicilian Gambit, SWORD trial, R, S-63
supraventricular arrhythmias, atrial fibrillation, ventricular tachiarrhythmias, MADIT
trial, EMIAT trial, Sicilian Gambit, ICD, R, S-66
vulnerable parameters, Sicilian Gambit, congenital long QT syndrom, atrial flutter,
atrial fibrillation, multiplicity of factors, ventricular fibrillation, R, S-65
|
TOP OF THE PAGE
|
Treatment of arrhythmias - pharmacological
management
arterial hypertension, myocardial remodeling, ventricular hyperophy, ventricular
dilatation, converting enzyme inhibitors, enalapril, angiotensin II receptor blockers,
ventricular arrhythmias, QT dispersion, OA, RT-155
chronic atrial fibrillation, flecainide, amiodarone, atropine, electrical
cardioversion, OA, RT-156
ibutilide, atrial fibrillation, atrial flutter, class III drugs, pharmacologic
conversion, procainamide, dl-sotalol, risk of torsade de pointes, R, S-112
malignant ventricular arrhythmias, sudden death, beta-blockers, amiodarone,
synergistic interaction, CAMIAT trial, EMIAT trial, GESICA trial, CHF-STAT trial, SCD-HeFT
trial, MADIT II trial, CASCADE trial, ESVEM trial, CASH trial, CIDS trial, AVID trial, R, RT-130
monomorphic ventricular tachycardia, survival, aetiology of heart disease, left
ventricular function, QRS-tachycardia morphology, clinical presentation, OA, RT-131
paroxysmal atrial flutter, transoesophageal atrial pacing/recording, flecainide,
overdrive pacing, burst of impulses, OA, RT-153
supraventricular paroxysmal tachyarrhythmias, ventricular extrasystols, sotalol, class
III drug, OA, RT-154
sustained ventricular arrhythmias, sudden death, beta-blockers, propranolol,
metoprolol, CAST trial, CASH trial, R, RT-129
|
TOP OF THE PAGE
|
T-wave interval
programmed ventricular stimulation, ventricular tachyarrhythmias, OA, RT-48
ventricular tachycardia, Holter ECG, myocardial infarction, OA, RT-45
|
|
|
|
